Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06432205
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-05-15
Brief Title:
The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer
Sponsor:
Peking University
Organization:
Peking University
Study Overview
Official Title:
The Effect of Multi-Disciplinary Team Plus Shared-Decision Making on Survival Benefit of Advanced Gastric Cancer - a Single Center Non-randomized Prospective Controlled Study
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to learn about the long-term effect of surgery in metastatic gastric cancer patients who are accessed as having opportunity for surgery under Multi-disciplinary Team MDT evaluation The main question it aims to answer is
Does surgery extend survival time in metastatic gastric cancer patients who are accessed as having opportunity for surgery under Multi-disciplinary Team MDT evaluation
Does surgery extend survival time in metastatic gastric cancer patients who are accessed as having opportunity for surgery under Multi-disciplinary Team MDT evaluation
Detailed Description:
Select metastatic gastric cancer patients that have the opportunity to undergo any forms of surgery through MDT Then further evaluate these patients risks and benefits Let patients make their finally decision through shared-decision making SDM According to the actual decision the patients are divided into surgery group and non-surgery group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None